Cargando…

Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains

BACKGROUND: Analyses of brain samples from Alzheimer’s disease (AD) patients may be expected to help us improve our understanding of the pathogenesis of AD. Bioactive lipids, including sphingolipids, glycerophospholipids, and eicosanoids/related mediators have been demonstrated to exert potent physi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurano, Makoto, Saito, Yuko, Uranbileg, Baasanjav, Saigusa, Daisuke, Kano, Kuniyuki, Aoki, Junken, Yatomi, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780287/ https://www.ncbi.nlm.nih.gov/pubmed/36570536 http://dx.doi.org/10.3389/fnagi.2022.1066578

Ejemplares similares

Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis
por: Uranbileg, Baasanjav, et al.
Publicado: (2021)

Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model
por: Uranbileg, Baasanjav, et al.
Publicado: (2019)

Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study
por: Kuwajima, Ken, et al.
Publicado: (2018)

Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence
por: Uranbileg, Baasanjav, et al.
Publicado: (2016)

Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human
por: Sato, Masaya, et al.
Publicado: (2016)

Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019)

Sphingosine 1‐phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids
por: Uranbileg, Baasanjav, et al.
Publicado: (2022)

Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation
por: Ishimaru, Kazuhiro, et al.
Publicado: (2019)

Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19
por: Kurano, Makoto, et al.
Publicado: (2022)

Lysophospholipids in laboratory medicine
por: YATOMI, Yutaka, et al.
Publicado: (2018)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy
por: Kageyama, Yuko, et al.
Publicado: (2020)

Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries
por: Kurano, Makoto, et al.
Publicado: (2022)

Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018)

Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid
por: Omi, Jumpei, et al.
Publicado: (2021)

Increase in serum levels of phosphatidylserine-specific phospholipase A(1) in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2021)

Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma
por: Uranbileg, Baasanjav, et al.
Publicado: (2020)

The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism
por: Harada, Sayaka, et al.
Publicado: (2023)

Decrease in serum levels of autotaxin in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2022)

Measurement of the Spatial Distribution of S1P in Small Quantities of Tissues: Development and Application of a Highly Sensitive LC-MS/MS Method Combined with Laser Microdissection
por: Wang, Jiao, et al.
Publicado: (2019)

Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression
por: Takahashi, Chiharu, et al.
Publicado: (2017)

Analysis of glycero-lysophospholipids in gastric cancerous ascites
por: Emoto, Shigenobu, et al.
Publicado: (2017)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
por: Nagai, Koshi, et al.
Publicado: (2019)

Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels
por: Enooku, Kenichiro, et al.
Publicado: (2016)

Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis
por: Kurano, Makoto, et al.
Publicado: (2022)

Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2021)

Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids
por: Kurano, Makoto, et al.
Publicado: (2015)

Bioactive lipids in intervertebral disc degeneration and its therapeutic implications
por: Das, Undurti N.
Publicado: (2019)

Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration
por: Ono, Yoshikazu, et al.
Publicado: (2013)

Analysis of urinary sphingolipids using liquid chromatography‐tandem mass spectrometry in diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2019)

Distributions of CHN compounds in meteorites record organic syntheses in the early solar system
por: Furukawa, Yoshihiro, et al.
Publicado: (2023)

Sphingosine 1-Phosphate and Atherosclerosis
por: Kurano, Makoto, et al.
Publicado: (2018)

Use of gas chromatography mass spectrometry to elucidate metabolites predicting the phenotypes of IgA nephropathy in hyper IgA mice
por: Kurano, Makoto, et al.
Publicado: (2019)

Urine autotaxin levels reflect the disease activity of sarcoidosis
por: Murakami, Koji, et al.
Publicado: (2022)

Natural bioactive compounds in Alzheimer's disease: From the perspective of type 3 diabetes mellitus
por: Huang, Juan, et al.
Publicado: (2023)

A New Enzyme Immunoassay for the Quantitative Determination of Classical Autotaxins (ATXα, ATXβ, and ATXγ) and Novel Autotaxins (ATXδ and ATXε)
por: Tokuhara, Yasunori, et al.
Publicado: (2015)

Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study
por: Edamura, Tatsuma, et al.
Publicado: (2022)

LipidClock: A Lipid-Based Predictor of Biological Age
por: Unfried, Maximilian, et al.
Publicado: (2022)

Autotaxin Overexpression Causes Embryonic Lethality and Vascular Defects
por: Yukiura, Hiroshi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f729vmsdp3i61j5inr0uescb9t